<DOC>
	<DOCNO>NCT02003131</DOCNO>
	<brief_summary>Allogeneic mesenchymal trophic factor ( MTF ) human umbilical cord tissue-derived mesenchymal stem cell ( UC-MSC ) inject knee joint 20 patient ( group 1 ) inject subcutaneously 20 patient ( group 2 ) safe useful procedure induce joint function improvement osteoarthritis ( OA ) patient grade 2 , 3 , 4 radiographic OA severity .</brief_summary>
	<brief_title>Safety Feasibility Study Mesenchymal Trophic Factor ( MTF ) Treatment Osteoarthritis</brief_title>
	<detailed_description>The propose study ass primary safety secondary efficacy endpoint allogeneic UC-MSC-derived MTF administer two arm osteoarthritis patient grade 2 , 3 , 4 radiographic OA severity ( 20 per arm ) . The first arm receive intra-articular injection MTF knee joint fluoroscopy . The second arm receive 12 subcutaneous MTF injection , per week . For arm , primary objective safety define freedom treatment associate adverse event period one year . The secondary objective efficacy include evaluation baseline month 3 12 efficacy endpoint joint function improvement assess Western Ontario McMaster Universities Osteoarthritis Index ( WOMAC ) .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>Age &gt; 18 year ability understand plan treatment . Subjects 18 year age old idiopathic secondary osteoarthritis knee grade 2 , 3 , 4 radiographic severity , define modify KellgrenLawrence classification Pregnant woman cognitively impaired adult . Presence large meniscal tear ( `` bucket handle '' tear ) , detect clinical examination magnetic resonance imaging . Inflammatory post infectious arthritis . More 5 degree varus valgus deformity . Kellgren Lawrence grade 4 osteoarthritis two compartment ( medial lateral compartment tibiofemoral joint patellofemoral compartment ) persons 60 year age . Intraarticular corticosteroid injection within previous 3 month . A major neurologic deficit . Serious medical illness life expectancy le 1 year . Prior admission substance abuse Body Mass Index ( BMI ) 40 kg/m2 great Patient receive experimental medication participate another clinical study within 30 day sign informed consent In opinion investigator sponsor patient unsuitable cellular therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>osteoarthritis</keyword>
	<keyword>umbilical cord</keyword>
	<keyword>mesenchymal</keyword>
	<keyword>stem cell</keyword>
	<keyword>trophic factor</keyword>
</DOC>